Myocyte enhancer factor 2D promotes tumorigenicity in malignant glioma cells.

about

Myocyte enhancer factor 2D promotes tumorigenicity in malignant glioma cells.

Item

http://www.wikidata.org/entity/Q38847239

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Myocyte enhancer factor 2D promotes tumorigenicity in malignant glioma cells.

@en

type

Item

label

Myocyte enhancer factor 2D promotes tumorigenicity in malignant glioma cells.

@en

prefLabel

Myocyte enhancer factor 2D promotes tumorigenicity in malignant glioma cells.

@en

P1476

Myocyte enhancer factor 2D promotes tumorigenicity in malignant glioma cells.

@en

P2093

Haidong Huang

http://www.w3.org/2001/XMLSchema#string

Jianwen Gu

http://www.w3.org/2001/XMLSchema#string

Jingmin Cheng

http://www.w3.org/2001/XMLSchema#string

Kexia Fan

http://www.w3.org/2001/XMLSchema#string

Songtao Wang

http://www.w3.org/2001/XMLSchema#string

Tao Yang

http://www.w3.org/2001/XMLSchema#string

Ying Li

http://www.w3.org/2001/XMLSchema#string

Yongqin Kuang

http://www.w3.org/2001/XMLSchema#string

Youguang Zhao

http://www.w3.org/2001/XMLSchema#string

Yuan Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy

IDH1 and IDH2 mutations in gliomas

Neuronal activity-dependent cell survival mediated by transcription factor MEF2

Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia

MEF2 protein expression, DNA binding specificity and complex composition, and transcriptional activity in muscle and non-muscle cells

In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival

Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesis.

Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.

Tumor-specific activation of the C-JUN/MELK pathway regulates glioma stem cell growth in a p53-dependent manner.

Rbfox2-coordinated alternative splicing of Mef2d and Rock2 controls myoblast fusion during myogenesis.

P2888

s13277-015-3791-6

P304

601-610

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-015-3791-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1029125113

http://www.w3.org/2001/XMLSchema#string

P698

26234765

http://www.w3.org/2001/XMLSchema#string